One thing I learned quickly as a caregiver is that much of the work happens where no one else can see it. Most people think of caregiving in clear, visible ways. They imagine helping someone stand, driving to appointments, or handling medications. These supporting acts are important, but…

Regulators in the U.S. and China have granted Xellsmart permission to start clinical testing of its experimental stem cell therapy in people with multiple system atrophy-Parkinsonian type (MSA-P). This is the fourth clinical trial program for Xellsmart’s stem cell therapy platform to have received regulatory clearance from both the…

The other day, I was thumbing through a few dated and crinkled copies of Good Housekeeping while waiting for a medical appointment, trying to relax. I tried to view the wasted time as an unexpected break from life, only to realize that I might be late for a meeting scheduled…

Japan’s Ministry of Health, Labour and Welfare has granted conditional approval to Amchepry, Sumitomo Pharma’s stem cell-derived therapy designed to replace dopamine-producing nerve cells, for people with Parkinson’s disease who do not respond adequately to existing treatments such as levodopa. The approval was based on results from a …

In the 12-plus years since I was diagnosed with Parkinson’s disease, I’ve become increasingly aware of how difficult the world is to navigate physically. When I started having gait and balance issues, I realized how many uneven flooring surfaces there were, all of which had become newly noticed…